Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of
Comparative analysis and meta-analysis of major clinical trials with oral factor Xa inhibitors versus warfarin in atrial fibrillation | Open Heart
60371-5.fp.png "OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL | Journal of the American College of Cardiology")
OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL | Journal of the American College of Cardiology
Cureus | Efficacy and Safety of Direct Factor Xa Inhibitors Versus Warfarin in Prevention of Primary and Secondary Ischemic Strokes in Non-Valvular Atrial Fibrillation: A Literature Review
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial | Journal of the American Heart Association
Eliquis®| Pfizer India | Apixaban | Randomized Clinical Trial
Prevention of Thromboembolism in Atrial Fibrillation: Factor XA and Thrombin Inhibitors | Basicmedical Key
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | NEJM
Safety Profile - NVAF | XARELTO® (rivaroxaban) HCP
![PDF] Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aa4fc6c0738765074752de78d1f997af8081cf42/5-Figure1-1.png "PDF] Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. | Semantic Scholar")
PDF] Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. | Semantic Scholar
CLINICAL REVIEW - Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation - NCBI Bookshelf
Efficacy of rivaroxaban to prevent stroke in atrial fibriallation maintained in elderly - PACE-CME
Key results from the ROCKET AF renal impairment subanalysis (19) | Download Table
Recent Advances in Oral Anticoagulation Therapy for Patients with Atrial Fibrillation
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - Journal of Stroke and Cerebrovascular Diseases
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF - The Lancet Neurology
RE-LY, ROCKET AF, and ARISTOTLE trial design and conduct. | Download Table
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF - Heart Rhythm O2
Recent Advances in Oral Anticoagulation Therapy for Patients with Atrial Fibrillation
Stroke Prevention in AF – A new Paradigm - ppt download
ROCKET AF Clinical Trial Executive Committee Releases Secondary Analysis | DAIC
